GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Tianjin TEDA Biomedical Engineering Co Ltd (HKSE:08189) » Definitions » 3-Year Book Growth Rate

Tianjin TEDA Biomedical Engineering Co (HKSE:08189) 3-Year Book Growth Rate : -31.20% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Tianjin TEDA Biomedical Engineering Co 3-Year Book Growth Rate?

Tianjin TEDA Biomedical Engineering Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.03.

During the past 12 months, Tianjin TEDA Biomedical Engineering Co's average Book Value per Share Growth Rate was -29.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was -31.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was -29.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was -17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Tianjin TEDA Biomedical Engineering Co was 19.10% per year. The lowest was -33.00% per year. And the median was 2.25% per year.


Competitive Comparison of Tianjin TEDA Biomedical Engineering Co's 3-Year Book Growth Rate

For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin TEDA Biomedical Engineering Co's 3-Year Book Growth Rate Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Tianjin TEDA Biomedical Engineering Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Tianjin TEDA Biomedical Engineering Co's 3-Year Book Growth Rate falls into.



Tianjin TEDA Biomedical Engineering Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Tianjin TEDA Biomedical Engineering Co  (HKSE:08189) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Tianjin TEDA Biomedical Engineering Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Tianjin TEDA Biomedical Engineering Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Business Description

Traded in Other Exchanges
N/A
Address
No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, medical and health products. It operates in two segments namely manufacturing and selling biological compound fertilizers and providing elderly care and health care services. The People's Republic of China is a primary geographical market for the company.
Executives
Long Ortiz 2101 Beneficial owner

Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Headlines

No Headlines